Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection

Clinical trial NCT02226952 · COMPLETED

Trial details

NCT number: NCT02226952
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2001-11-01
Primary completion: 2002-04-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.